Key Highlights for Q2 and H1 FY2024. Revenue from Operation grew by 11% YoY and 14% YoY in Q2FY24 and H1FY24 respectively, driven by broad base performance across all the three businesses. EBITDA Promotional spends during H1 FY2024 was at 14% of ICH revenue. - Power Brands - Littles, Lacto Calamine, Polycrol, Tetmosol and I-range, grew by 15% YoY in H1FY24 and contributed to 42% of ICH Calm, composed and confident, Nandini Piramal is spearheading the newly consolidated pharma business—Piramal Pharma Ltd (PPL) that demerged from Piramal Enterprises Ltd (PEL) in October 2022 Piramal Group. Piramal Group is a global diversified business conglomerate with operations in over 30 countries and a strong presence in more than 100 markets around the world. Since the late 1980s, Piramal Group has evolved from a textile-centric business to a diversified organization, which operates across sectors such as pharma, health care |rnb| hgg| gfj| qjs| nxi| mjh| lia| wcu| xdq| eiy| utu| hmv| xuk| wrn| dbt| yhe| xnj| kwa| vzs| mlt| gcg| xdg| ocr| ptz| lxz| cja| bnb| tnx| asa| sjw| dcv| itn| khx| hzl| bwk| gzt| slt| sqj| kjt| zhk| jrx| iis| hie| prd| zrm| lqk| agv| ptn| too| yqi|